New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 24, 2014
10:00 EDTINWK, SO, MEOH, IDXX, WEC, OXLC, MTOR, SRC, MU, CDE, CGG, HTGCOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: CGG SA (CGG) upgraded to Buy from Hold at Societe Generale... Coeur Mining (CDE) upgraded at BMO Capital... Hercules Technology (HTGC) upgraded to Outperform from Market Perform at Wells Fargo... IDEXX (IDXX) upgraded to Buy from Hold at Canaccord... InnerWorkings (INWK) upgraded to Buy from Hold at Craig-Hallum... Meritor (MTOR) upgraded to Buy from Fair Value at CRT Capital... Methanex (MEOH) upgraded at BMO Capital... Micron (MU) upgraded to Strong Buy with $50 price target at Needham... Oxford Lane (OXLC) upgraded to Buy from Neutral at Ladenburg... Southern Company (SO) upgraded to Buy from Hold at Argus... Spirit Realty (SRC) upgraded at BofA/Merrill... Wisconsin Energy (WEC) upgraded to Outperform from Market Perform at Wells Fargo.
News For CGG;CDE;HTGC;IDXX;INWK;MTOR;MEOH;MU;OXLC;SO;SRC;WEC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
July 23, 2015
08:34 EDTIDXXIDEXX upgraded to Hold from Sell at Feltl
Feltl upgraded IDEXX to Hold and increased its price target to $69.50 from $61.50 based on an improved growth outlook and valuation.
06:42 EDTMUMobile DRAM prices to fall on excess smartphone inventory, DigiTimes reports
Subscribe for More Information
06:42 EDTMUTsinghua still in talks with Micron over possible takeover, Reuters reports
Subscribe for More Information
06:29 EDTMUMicron and Tsinghua fail to reach consensus in tie-up talks, DigiTimes reports
Micron and Tsinghua Unigroup failed to reach a consensus although it is negotiating a possible tie-up in DRAM business, reports DigiTimes. According to industry sources, Micron wanted to have absolute control over the production capacity the company would share with Tsinghua while the China chipmaker had no interest in just being a manufacturing partner of the US vendor. The sources add that Tsinghua could be the one spreading the rumors that it is looking to make an offer for Micron. Reference Link
06:20 EDTSRCSpirit Realty downgraded to Equal Weight from Overweight at Morgan Stanley
Subscribe for More Information
July 22, 2015
19:02 EDTMUOn The Fly: After Hours Movers
Subscribe for More Information
17:33 EDTMUMicron advances by 2.33% after SanDisk Q2 results
Subscribe for More Information
15:02 EDTMUOptions Update; July 22, 2015
Subscribe for More Information
10:21 EDTMUTsinghua 'sounding out' Micron interest in deal, to make $23B bid, Nikkei says
Subscribe for More Information
05:55 EDTMUDRAMeXchange: DRAM prices to fall further, DigiTimes says
Subscribe for More Information
July 21, 2015
15:40 EDTSOGeorgia Power receives approval for Albany solar project
Subscribe for More Information
10:04 EDTMUMicron spurning of Tsinghua a 'bargaining tactic,' blog author contends
Subscribe for More Information
05:39 EDTCGGCGG SA awarded contract by TPDC
Subscribe for More Information
July 20, 2015
16:01 EDTMUOptions Update; July 20, 2015
Subscribe for More Information
13:18 EDTMUOptions with increasing call volume
Subscribe for More Information
13:10 EDTMUMicron calls Tsinghua takeover offer unrealistic, Reuters reports
Micron has told Tsinghua Unigroup that its $23B takeover offer is unrealistic due to U.S. national security concerns, reports Reuters, citing people familiar with the matter. Sources said Micron believes the Committee on Foreign Investment in the United States, a government task force which Reuters notes has the power to stop mergers that threaten national security, would not approve Tsinghua's proposed deal. Micron has not formally hired an investment bank because it is not seriously considering Tsinghua's offer, the sources added. Reference Link
12:58 EDTMUMicron does not think U.S. would approve deal with Tsinghua, Reuters reports
Subscribe for More Information
10:17 EDTMUHigh option volume stocks
Subscribe for More Information
09:34 EDTMUActive equity options trading on open
Subscribe for More Information
08:38 EDTIDXXAnalyst predicts Zoetis merges with Bayer unit, not Valeant
Zoetis (ZTS) in recent months has been the subject of takeover speculation, possibly for Valeant (VRX), but a Jefferies analyst told investors today in a research note that he views a deal with a unit of healthcare giant Bayer (BAYRY) as "highly likely" for the animal medicine company. BACKGROUND: Bill Ackman of Pershing Square, who owns stakes in both Zoetis and Valeant, said in early May while speaking on CNBC that Zoetis is a "great” business on a standalone basis, but he also spoke of the company's strategic value. Ackman added, however, that he was "not sure" that Valeant was the best acquirer of Zoetis. Subsequently, in late June, The Wall Street Journal reported that Valeant made a preliminary approach regarding a potential deal to buy Zoetis. CNBC's David Faber said the next day, citing his own sources, that Valeant reached out to Zoetis as a courtesy to common shareholder Ackman and was unlikely to pursue an acquisition of the company, though he cautioned then Valeant could change its approach and pursue a deal. BAYER: Jefferies analyst Jeffrey Holford said in a note today that he views a tie-up between Zoetis and Bayer's Animal Health business in 2016 as "highly likely." He sees Mylan's (MYL) acquisition of Abbott's (ABT) non‑U.S. developed markets specialty and branded generics business as a potential proxy for how a transaction could be structured, adding that such a "spinversion" could achieve up to 36% long-term earnings accretion for Zoetis. Holford reiterated a Buy rating on Zoetis with a $60 price target, while downgrading Bayer to Hold, citing valuation following the recent outperformance of its shares. IDEXX: While being discussed as a target, some analysts have also opined on companies that Zoetis could pursue as a buyer. On June 29, Canaccord said that in investor meetings with IDEXX (IDXX) executives declined to comment on Zoetis' potential interest in scaling up its animal health diagnostics business. Canaccord added that it thought Zoetis could make a bid for IDEXX. The firm reiterated its Buy rating and $80 price target on IDEXX shares at that time. PRICE ACTION: Since June 25, the day the Journal first reported on Valeant's preliminary takeover approach to Zoetis, the animal health company's shares have dropped nearly 4%. Zoetis closed down 20c to $47.80 on Friday.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use